AwardTape · Defense awards · Medical · Drugs and biologicals · HT942626CE004
HT942626CE004: $49K definitive contract to Zen-Bio, Inc
Zen-Bio, Inc holds a definitive contract from Defense Health Agency with $49K obligated since Oct 2023, against a ceiling of $251K. Latest action Mar 30, 2026.
Human blood for research utilizing malaria parasite cultures
| PIID | HT942626CE004 |
|---|---|
| Type | definitive contract |
| Company | Zen-Bio, Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Medical · Drugs and biologicals |
| PSC | 6506 BLOOD AND BLOOD PRODUCTS |
| NAICS | 325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING |
| Obligated since Oct 2023 | $49K |
| Total obligated (lifetime) | $49K |
| Ceiling (base and all options) | $251K |
| Base date | Mar 19, 2026 |
| Latest action | Mar 30, 2026 |
| End date | Feb 22, 2031 |
| Actions since Oct 2023 | 2 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | NC |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial